Home LiteratureArticle Details
PMID: 3119471 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis.

Immunology ·Vol. 62 ·No. 2 ·1987-10-00 ·Pages 229-34

Rook GA, Taverne J, Leveton C, Steele J

Abstract

Endotoxin (LPS)-triggered release of tumour necrosis factor (TNF) from human monocytes is high for the first 3 days in culture, and then falls to a trough between Days 4 and 6. This trough is less deep if the cells are cultured in the presence of indomethacin. If monocytes are cultured in the presence of either recombinant gamma-interferon or 1,25-(OH)2 vitamin D3, their capacity for LPS-triggered TNF release is increased. Live virulent Mycobacterium tuberculosis can substitute for the LPS, and is markedly more effective as a trigger than several strains of BCG prepared in an identical manner. Since secretion of IFN-gamma and conversion of circulating 25-(OH) vitamin D3 to the active dihydroxy metabolite by interferon-activated macrophages probably occur in tuberculosis, we suggest that triggering of TNF release from the resulting activated macrophage populations might explain much of the weight loss and tissue damage that characterize this disease. IFN-gamma does not activate effective anti-mycobacterial mechanisms in human monocytes, so its role in tuberculosis may be immunopathological rather than protective.

MeSH Terms
Antigens, Bacterial/immunology Calcitriol/pharmacology Cells, Cultured Drug Synergism Humans Indomethacin/pharmacology Interferon-gamma/pharmacology Lipopolysaccharides/pharmacology Monocytes/metabolism Mycobacterium bovis/immunology Mycobacterium tuberculosis/immunology Tuberculosis/etiology,immunology Tumor Necrosis Factor-alpha/metabolism
Chemicals
Antigens, Bacterial Lipopolysaccharides Tumor Necrosis Factor-alpha Interferon-gamma Calcitriol Indomethacin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Rook G A
Department of Bacteriology, Middlesex Hospital Medical School, London, U.K.
Taverne J
Leveton C
Steele J
References (31)
31 references, click to expand
  1. [Does calciferol have a liquifying action on caseum?].
    Poumon Coeur. 1967;23(7):841-51 PMID: 5300595
  2. Non-reactive tuberculosis.
    J Clin Pathol. 1954 Aug;7(3):216-25 PMID: 13192197
  3. The dissociation of adjuvant properties of mycobacterial components from mitogenicity, and from the ability to induce the release of mediators from macrophages.
    Immunology. 1976 Sep;31(3):389-96 PMID: 800406
  4. Production of an anti-tumour cytotoxin by human monocytes.
    Immunology. 1981 Sep;44(1):135-42 PMID: 7275181
  5. Production of an anti-tumour cytotoxin by human monocytes: comparison of endotoxin, interferons and other agents as inducers.
    Br J Cancer. 1982 Apr;45(4):615-7 PMID: 6176252
  6. Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.
    Clin Exp Immunol. 1983 Mar;51(3):501-10 PMID: 6342884
  7. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
    J Cell Biol. 1984 Feb;98(2):391-8 PMID: 6319426
  8. Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages.
    J Leukoc Biol. 1984 Jan;35(1):1-10 PMID: 6323600
  9. Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.
    J Immunol. 1984 Aug;133(2):764-8 PMID: 6330202
  10. Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.
    Clin Exp Immunol. 1984 Aug;57(2):293-300 PMID: 6467675
  11. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis.
    J Exp Med. 1985 Apr 1;161(4):755-65 PMID: 3838552
  12. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  13. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
    J Immunol. 1985 Oct;135(4):2492-7 PMID: 3928750
  14. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.
    Infect Immun. 1985 Oct;50(1):1-8 PMID: 3930401
  15. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.
    J Immunol. 1985 Dec;135(6):3969-71 PMID: 2999235
  16. Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity.
    Immunology. 1985 Nov;56(3):441-9 PMID: 2416675
  17. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis.
    Am Rev Respir Dis. 1986 Jan;133(1):73-7 PMID: 2935057
  18. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes.
    Immunology. 1986 Jan;57(1):159-63 PMID: 3002968
  19. Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives.
    Cancer Immunol Immunother. 1986;21(2):93-9 PMID: 3081250
  20. The role of monocyte cytotoxic factor in monocyte-mediated lysis of tumour cells.
    Immunology. 1986 Feb;57(2):255-9 PMID: 3081437
  21. Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
    J Exp Med. 1986 Mar 1;163(3):740-5 PMID: 3753996
  22. Interleukin-1 released by blood-monocyte-derived macrophages from patients with leprosy.
    Infect Immun. 1986 Apr;52(1):303-8 PMID: 3514458
  23. A monosaccharide precursor of Escherichia coli lipid A has the ability to induce tumor-cytotoxic factor production by a murine macrophage-like cell line, J774.1.
    J Immunol. 1986 Jun 1;136(11):4122-7 PMID: 3701065
  24. Cachectin and tumour necrosis factor as two sides of the same biological coin.
    Nature. 1986 Apr 17-23;320(6063):584-8 PMID: 3010124
  25. Participation of tumor killing factor in the antitumor effect of Sarcophaga lectin.
    FEBS Lett. 1986 May 26;201(1):37-40 PMID: 3709806
  26. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation.
    Immunopharmacology. 1986 Apr;11(2):79-86 PMID: 3710767
  27. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
    J Exp Med. 1986 Jun 1;163(6):1433-50 PMID: 3486936
  28. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7 PMID: 3487091
  29. Regulation of macrophage tumor necrosis factor production by prostaglandin E2.
    Biochem Biophys Res Commun. 1986 May 29;137(1):404-10 PMID: 3459461
  30. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.
    Immunology. 1986 Nov;59(3):333-8 PMID: 3098676
  31. Endotoxin-induced hepatic damage in BCG-infected mice.
    Am J Pathol. 1972 Apr;67(1):23-40 PMID: 4558221
Article Info
Journal
Immunology
Abbr.
Immunology
ISSN
0019-2805
Published
1987-10-00
Pages
229-34
Language
English
Region
England
NLM ID
0374672
PMCID
PMC1453980
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com